Latest / Gene Peroni's Daily Podcast
June 25, 2024
Biotechnology was a glistening theme in yesterday’s session. An FDA approval on a drug and positive test results for another drug spurred big gains in 2 of the biotech stocks, which put the focus on healthcare generally, once again.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.